New findings by the Translational Genomics Research Institute, or TGen, point to a surprising pattern in the brain cancer glioblastoma multiforme (GBM), the most common and deadly type of gliomas.

GBMs are aggressive, invasive and so genetically and structurally complex that advanced, targeted therapies have struggled to find vulnerabilities to attack.

Read/listen to my full story at KJZZ’s Arizona Science Desk:
TGen Brain Cancer Study Finds Surprising Benefit In Tumor Complexity